Publications
Publications
Show Results For
- All HBS Web
(557)
- Faculty Publications (188)
- March 1994 (Revised April 1994)
- Case
Eli Lilly and Co.: The Flexible Facility Decision--1993
By: Gary P. Pisano
In 1993, Eli Lilly is preparing to build manufacturing capacity for three new pharmaceutical products that it expects to launch in 1996. Management wrestles with a decision of whether to add specialized manufacturing capacity or flexible capacity. This question touches... View Details
- August 1993
- Case
Applichem (A) (Abridged)
By: Janice H. Hammond and Gary P. Pisano
Applichem manufactures the same chemical product in four plants, each of which is located in a different country. The company has completed a major study comparing the productivity and performance of these plants. Using the data from the study, students must decide... View Details
- October 1992 (Revised December 1992)
- Case
American Connector Company (A)
By: Gary P. Pisano
American Connector Co. is forced to reexamine operations at its Sunnyvale plant when a Japanese competitor announces plans to build an "ultimate" plant in the United States. Case examines issues related to benchmarking a competitor's manufacturing capabilities and... View Details
- October 1992
- Supplement
American Connector Co. (B)
By: Gary P. Pisano
Presents a plant manager's proposal to improve operations at American Connector Co. The plan attempts to imitate operations at DJC Corp., a successful Japanese competitor. Requires students to consider how changes in manufacturing impact productivity, flexibility, and... View Details
- May 1992 (Revised February 1996)
- Teaching Note
Nucleon, Inc., Teaching Note
By: Gary P. Pisano
Teaching Note for (9-692-041). View Details
Keywords: Biotechnology Industry
- May 1992 (Revised November 1994)
- Teaching Note
Eli Lilly and Co.: Manufacturing Process Technology Strategy--1991, Teaching Note
By: Gary P. Pisano
Teaching Note for (9-692-056). View Details
Keywords: Manufacturing Industry
- May 1992
- Teaching Note
Whistler Corp. (A) and (B), Teaching Note
By: Gary P. Pisano
Teaching Note for (9-690-011) and (9-692-072). View Details
- March 1992 (Revised April 1995)
- Teaching Note
BMW: The 7-Series Project (A), Teaching Note
By: Gary P. Pisano
Teaching Note for (9-692-083). View Details
- February 1992 (Revised January 2002)
- Case
BMW: The 7-Series Project (A)
By: Gary P. Pisano
Explores BMW's decision about how to manufacture prototype vehicles. Historically, BMW's prototypes were handcrafted by highly skilled artisans in the company's shop. A proposal has been made to alter the process so that prototypes are made in a way that can better... View Details
- December 1991
- Supplement
Whistler Corp. (B)
By: Gary P. Pisano and David T. Kotchen
Describes the decision the company chose and how it worked out. Designed as an in-class follow-up to Whistler Corp. (A). View Details
- November 1991 (Revised April 1994)
- Case
Nucleon, Inc.
By: Gary P. Pisano
Nucleon is a small biotechnology company whose first potential product is about to enter clinical testing. Before Nucleon can begin clinical trials, however, its management must decide how and where to manufacture the product. Three options are being contemplated: 1)... View Details
- 1991
- Working Paper
Manufacturing, Firm Boundaries, and the Protection of Intellectual Property
By: Gary P. Pisano and Paul Mang
- February 1990 (Revised March 1992)
- Background Note
Biotechnology: A Technical Note
By: Gary P. Pisano
- February 1990 (Revised July 1992)
- Case
Whistler Corp. (A)
By: Gary P. Pisano
Describes the circumstances surrounding Whistler Corp.'s decision whether or not to continue manufacturing operations in the United States. The company had been experiencing severe problems in its domestic manufacturing operations and was thus unable to compete with... View Details
- January 1990 (Revised October 1993)
- Case
Monsanto's March into Biotechnology (A)
By: Gary P. Pisano
Very early in the history of biotechnology (about 1979), Monsanto made a major commitment to move into this field. This case recounts the history from the point of view of the eminent scientist hired to head up corporate R&D. He took Monsanto from a very traditional... View Details